164 related articles for article (PubMed ID: 32568769)
1. Association Between CD4 Count and Chemoradiation Therapy Outcomes Among Cervical Cancer Patients With HIV.
Grover S; Mehta P; Wang Q; Bhatia R; Bvochora-Nsingo M; Davey S; Iyengar M; Shah S; Shin SS; Zetola NM
J Acquir Immune Defic Syndr; 2020 Oct; 85(2):201-208. PubMed ID: 32568769
[TBL] [Abstract][Full Text] [Related]
2. Impact of Human Immunodeficiency Virus Infection on Survival and Acute Toxicities From Chemoradiation Therapy for Cervical Cancer Patients in a Limited-Resource Setting.
Grover S; Bvochora-Nsingo M; Yeager A; Chiyapo S; Bhatia R; MacDuffie E; Puri P; Balang D; Ratcliffe S; Narasimhamurthy M; Gwangwava E; Tsietso S; Kayembe MKA; Ramogola-Masire D; Dryden-Peterson S; Mahantshetty U; Viswanathan AN; Zetola NM; Lin LL
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):201-210. PubMed ID: 29619965
[TBL] [Abstract][Full Text] [Related]
3. HIV infection is not associated with the initiation of curative treatment in women with cervical cancer in Botswana.
Grover S; MacDuffie EC; Wang Q; Bvochora-Nsingo M; Bhatia RK; Balang D; Chiyapo SP; Luckett R; Ramogola-Masire D; Dryden-Peterson SL; Lin LL; Shin SS; Zetola NM
Cancer; 2019 May; 125(10):1645-1653. PubMed ID: 30801696
[TBL] [Abstract][Full Text] [Related]
4. HIV Infection and Survival Among Women With Cervical Cancer.
Dryden-Peterson S; Bvochora-Nsingo M; Suneja G; Efstathiou JA; Grover S; Chiyapo S; Ramogola-Masire D; Kebabonye-Pusoentsi M; Clayman R; Mapes AC; Tapela N; Asmelash A; Medhin H; Viswanathan AN; Russell AH; Lin LL; Kayembe MKA; Mmalane M; Randall TC; Chabner B; Lockman S
J Clin Oncol; 2016 Nov; 34(31):3749-3757. PubMed ID: 27573661
[TBL] [Abstract][Full Text] [Related]
5. Chemoradiation versus radiation alone in stage IIIB cervical cancer patients with or without human immunodeficiency virus.
Grover S; Ning MS; Bale M; Lichter KE; Shah S; Bvochora-Nsingo M; Chiyapo S; Balang D; McGinnis GJ; Ralefala T; Moloi T; Luckett R; Ramogola-Masire D; Robertson ES; Zetola NM
Int J Gynecol Cancer; 2021 Sep; 31(9):1220-1227. PubMed ID: 34312220
[TBL] [Abstract][Full Text] [Related]
6. Five-year overall survival following chemoradiation among HIV-positive and HIV-negative patients with locally advanced cervical carcinoma in a South African cohort.
Simonds HM; Botha MH; Neugut AI; Van Der Merwe FH; Jacobson JS
Gynecol Oncol; 2018 Nov; 151(2):215-220. PubMed ID: 30194006
[TBL] [Abstract][Full Text] [Related]
7. CD4/CD8 Ratio and CD4 Nadir Predict Mortality Following Noncommunicable Disease Diagnosis in Adults Living with HIV.
Castilho JL; Turner M; Shepherd BE; Koethe JR; Furukawa SS; Bofill CE; Raffanti S; Sterling TR
AIDS Res Hum Retroviruses; 2019 Oct; 35(10):960-967. PubMed ID: 31407605
[TBL] [Abstract][Full Text] [Related]
8. Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA study.
Miller V; Mocroft A; Reiss P; Katlama C; Papadopoulos AI; Katzenstein T; van Lunzen J; Antunes F; Phillips AN; Lundgren JD
Ann Intern Med; 1999 Apr; 130(7):570-7. PubMed ID: 10189326
[TBL] [Abstract][Full Text] [Related]
9. Five-year overall survival following chemoradiation therapy for locally advanced cervical carcinoma in women living with and without HIV infection in Botswana.
MacDuffie E; Bvochora-Nsingo M; Chiyapo S; Balang D; Chambers A; George JM; Tuli S; Lin LL; Zetola NM; Ramogola-Masire D; Grover S
Infect Agent Cancer; 2021 Aug; 16(1):55. PubMed ID: 34344430
[TBL] [Abstract][Full Text] [Related]
10. Effect of BMI and fat mass on HIV disease progression in HIV-infected, antiretroviral treatment-naïve adults in Botswana.
Martinez SS; Campa A; Bussmann H; Moyo S; Makhema J; Huffman FG; Williams OD; Essex M; Marlink R; Baum MK
Br J Nutr; 2016 Jun; 115(12):2114-21. PubMed ID: 27087233
[TBL] [Abstract][Full Text] [Related]
11. Utility of CD4 count measurement in the era of universal antiretroviral therapy: an analysis of routine laboratory data in Botswana.
Leeme TB; Mine M; Lechiile K; Mulenga F; Mosepele M; Mphoyakgosi T; Muthoga C; Ngidi J; Nkomo B; Ramaabya D; Tau M; Tenforde MW; Hayes R; Jarvis JN
HIV Med; 2021 Jan; 22(1):1-10. PubMed ID: 32876378
[TBL] [Abstract][Full Text] [Related]
12. Significance of HIV status in cervical cancer patients receiving curative chemoradiation therapy, definitive radiation alone, or palliative radiation in Botswana.
Meghani K; Puri P; Bazzett-Matabele L; Vuylsteke P; Luckett R; Monare B; Chiyapo S; Ketlametswe R; Ralefala TB; Bvochora-Nsingo M; Zetola N; Ramogola-Masire D; Grover S
Cancer; 2024 Mar; ():. PubMed ID: 38529676
[TBL] [Abstract][Full Text] [Related]
13. Completion of and early response to chemoradiation among human immunodeficiency virus (HIV)-positive and HIV-negative patients with locally advanced cervical carcinoma in South Africa.
Simonds HM; Wright JD; du Toit N; Neugut AI; Jacobson JS
Cancer; 2012 Jun; 118(11):2971-9. PubMed ID: 22072021
[TBL] [Abstract][Full Text] [Related]
14. Effect of baseline CD4 cell count at linkage to HIV care and at initiation of antiretroviral therapy on mortality in HIV-positive adult patients in Rwanda: a nationwide cohort study.
Nsanzimana S; Remera E; Kanters S; Forrest JI; Ford N; Condo J; Binagwaho A; Bucher H; Thorlund K; Vitoria M; Mills EJ
Lancet HIV; 2015 Sep; 2(9):e376-84. PubMed ID: 26423551
[TBL] [Abstract][Full Text] [Related]
15. Distance to Multidisciplinary Team Clinic in Gaborone, Botswana, and Stage at Cervical Cancer Presentation for Women Living With and Without HIV.
Friebel-Klingner TM; Bazzett-Matabele L; Ramogola-Masire D; Monare B; Ralefala TB; Seiphetlheng A; Ramontshonyana G; Vuylsteke P; Mitra N; Wiebe DJ; Rebbeck TR; McCarthy AM; Grover S
JCO Glob Oncol; 2022 Nov; 8():e2200183. PubMed ID: 36395437
[TBL] [Abstract][Full Text] [Related]
16. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
Kokka F; Bryant A; Brockbank E; Powell M; Oram D
Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
[TBL] [Abstract][Full Text] [Related]
17. Early postseroconversion CD4 cell counts independently predict CD4 cell count recovery in HIV-1-postive subjects receiving antiretroviral therapy.
Kulkarni H; Okulicz JF; Grandits G; Crum-Cianflone NF; Landrum ML; Hale B; Wortmann G; Tramont E; Polis M; Dolan M; Lifson AR; Agan BK; Ahuja SK; Marconi VC
J Acquir Immune Defic Syndr; 2011 Aug; 57(5):387-95. PubMed ID: 21546844
[TBL] [Abstract][Full Text] [Related]
18. Differences in Outcomes of Chemoradiation in Women With Invasive Cervical Cancer by Human Immunodeficiency Virus Status: A Systematic Review.
Shah S; Xu M; Mehta P; Zetola NM; Grover S
Pract Radiat Oncol; 2021; 11(1):53-65. PubMed ID: 32428763
[TBL] [Abstract][Full Text] [Related]
19. Antiretroviral treatment initiation among HIV-infected pregnant women with low CD4(+) cell counts in Gaborone, Botswana.
Chen JY; Ogwu AC; Svab P; Lockman S; Moffat HJ; Gaolathe T; Moilwa S; Størdal K; Dryden-Peterson S; Moffat C; Makhema J; Essex M; Shapiro RL
J Acquir Immune Defic Syndr; 2010 May; 54(1):102-6. PubMed ID: 19864957
[TBL] [Abstract][Full Text] [Related]
20. Stage and outcomes of invasive cervical cancer patients in Botswana: A prospective cohort study from 2013 to 2020.
Grover S; George J; Tuli S; Lichter K; Bhatia R; Monare B; Chinniah G; Bazzett-Matabele L; Bvochora-Nsingo M; Chiyapo S; Balang D; Ralefala T; Vuylsteke P; Luckett R; Shin S; Zetola N; Ramogola-Masire D
Gynecol Oncol Rep; 2022 Dec; 44():101094. PubMed ID: 36337265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
